Mitsu Chem Plast Ltd
BSE:540078
Mitsu Chem Plast Ltd
Mitsu Chem Plast Ltd. engages in the manufacture of plastic blow molded and injection molded products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2016-09-09. The firm's container product group includes blow-molded and injection molded products, ranging from 100 milliliters (ml) to 250 ml, which includes bottles, jerry cans and drums. Its hospital furniture parts product group includes hospital bed parts, hospital bed accessories, side trolleys, safety equipment, accessories, actuators, overbed tables and spine board, among others. Its automotive product group consists of air intake duct, rain hood plastic, washer tanks, air conditioner (AC) ducting pipe and water tanks, among others. Its other product group consists of blow-molded chairs and medical devices, such as pregnancy kit, malaria kit and human immunodeficiency virus (HIV) kit. Its molded industrial packaging products include full open top drum, jerry cans and narrow mouth drums, among others.
Mitsu Chem Plast Ltd. engages in the manufacture of plastic blow molded and injection molded products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2016-09-09. The firm's container product group includes blow-molded and injection molded products, ranging from 100 milliliters (ml) to 250 ml, which includes bottles, jerry cans and drums. Its hospital furniture parts product group includes hospital bed parts, hospital bed accessories, side trolleys, safety equipment, accessories, actuators, overbed tables and spine board, among others. Its automotive product group consists of air intake duct, rain hood plastic, washer tanks, air conditioner (AC) ducting pipe and water tanks, among others. Its other product group consists of blow-molded chairs and medical devices, such as pregnancy kit, malaria kit and human immunodeficiency virus (HIV) kit. Its molded industrial packaging products include full open top drum, jerry cans and narrow mouth drums, among others.
Revenue Growth: Mitsu Chem Plast delivered 6.92% year-on-year growth in total income for Q3 FY26, reaching INR 8,608.85 lakhs.
Margin Expansion: EBITDA margin rose sharply to 11.10%, up 426 basis points year-on-year, with EBITDA up 73.35% and net profit up 217.03%.
Niche Segment Contribution: Niche products contributed roughly 16% of revenue, with higher margins than commodity products. Management aims to increase this share to 15–20% by FY28.
Capacity Expansion: Plans are in place to double capacity to achieve the INR 1,000 crore revenue target by FY28, with incremental expansions already announced.
Sustainable EBITDA Margin: Management expects 8–10% EBITDA margin to be a reasonable range, with potential for further improvement as scale increases.
Export Potential: Exports currently account for 2.5% of revenue, mostly from niche products, with significant growth expected as new markets open.
Working Capital Cycle: The working capital cycle remains at 65–70 days, with debtor days between 60–65 days.
FY27 Guidance: Revenue for FY27 is expected to remain in line with historical growth, with a stronger focus on profitability before a larger ramp-up towards FY28.
